Alto Neuroscience to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Alto Neuroscience (NYSE: ANRO), a clinical-stage biopharmaceutical company developing precision medicines for neuropsychiatric disorders, has announced its participation in three upcoming investor conferences in March 2025:

1. TD Cowen 45th Annual Health Care Conference (March 3-5, 2025)
- Presentation: Tuesday, March 4, 2025, at 9:50 am ET
- Location: Marriott Copley Place, Boston, MA

2. Leerink's Global Healthcare Conference 2025 (March 10-12, 2025)
- Presentation: Wednesday, March 12, 2025, at 8:00 am ET
- Location: W South Beach, Miami, FL

3. Stifel 2025 Virtual CNS Forum (March 18-19, 2025)
- Presentation: Tuesday, March 18, 2025, at 1:00 pm ET

All available presentations will be accessible via live webcast on the Events and Presentations page in the Investors section of Alto's website, with replays available following each presentation.

Positive

• Alto Neuroscience is actively engaging with investors through multiple high-profile healthcare conferences
• The company is maintaining visibility in the investment community with three scheduled presentations in March 2025
• Alto provides transparent investor access through webcasts of their presentations

Negative

• The press release doesn't provide specific details about Alto's drug pipeline or development progress
• No information is provided about the company's financial position or recent performance
• The announcement lacks details about the specific topics to be discussed at these conferences

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company management team will present at the following upcoming investor conferences and events in March:

• TD Cowen 45^th Annual Health Care Conference, March 3-5^th 2025:
  • Format: Presentation and one-on-one investor meetings
  • Presentation Date/Time: Tuesday, March 4, 2025, at 9:50 am ET
  • Location: Marriott Copley Place, Boston, MA
• Leerink’s Global Healthcare Conference 2025, March 10-12^th 2025:
  • Format: Presentation and one-on-one investor meetings
  • Presentation Date/Time: Wednesday, March 12, 2025, at 8:00 am ET
  • Location: W South Beach, Miami, FL
• Stifel 2025 Virtual CNS Forum, March 18-19^th 2025:
  • Format: Presentation and one-on-one investor meetings
  • Presentation Date/Time: Tuesday, March 18, 2025, at 1:00 pm ET

Available presentations will be accessible via a live webcast on the Events and Presentations page in the Investors section of Alto’s website and a replay will be available following the presentation.

About Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto’s Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, schizophrenia, and other mental health conditions. For more information, visit www.altoneuroscience.com or follow Alto on X.

Availability of Information on Alto’s Website

Alto routinely uses its investor relations website to post presentations to investors and other important information, including information that may be material. Accordingly, Alto encourages investors and others interested in Alto to review the information it makes public on its investor relations website.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225919531/en/

Investor Contact:

Nick Smith

investors@altoneuroscience.com

Media Contact:

Mari Purpura

media@altoneuroscience.com

Source: Alto Neuroscience, Inc.

FAQ

When is Alto Neuroscience (ANRO) presenting at the TD Cowen Health Care Conference in 2025?

Alto Neuroscience (ANRO) will present at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025, at 9:50 am ET at the Marriott Copley Place in Boston, MA.

Which investor conferences will Alto Neuroscience (ANRO) attend in March 2025?

In March 2025, Alto Neuroscience (ANRO) will participate in three investor conferences: TD Cowen 45th Annual Health Care Conference (March 3-5), Leerink's Global Healthcare Conference (March 10-12), and Stifel 2025 Virtual CNS Forum (March 18-19).

How can investors access Alto Neuroscience's (ANRO) presentations from the March 2025 conferences?

Investors can access Alto Neuroscience's (ANRO) presentations via live webcast on the Events and Presentations page in the Investors section of Alto's website. Replays will also be available following each presentation.

What is the focus of Alto Neuroscience's (ANRO) drug development pipeline?

Alto Neuroscience (ANRO) is a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders.

Where and when will Alto Neuroscience (ANRO) present at Leerink's Global Healthcare Conference 2025?

Alto Neuroscience (ANRO) will present at Leerink's Global Healthcare Conference 2025 on Wednesday, March 12, 2025, at 8:00 am ET at the W South Beach in Miami, FL.